Rx (Prescription Medicine)
USD $ 120.00
Ontramab 150毫克注射液是一种针对特定类型癌症的靶向治疗药物，通过注射给药。它通过抑制癌细胞生长发挥作用，且必须在严格的医疗监督下使用。
Ontramab 150毫克注射液是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分Ontramab是一种单克隆抗体，旨在特异性靶向并抑制癌细胞的生长。本药物通过注射给药，通常作为综合癌症治疗方案的一部分进行处方。它通过干扰癌细胞赖以生存和增殖的特定通路发挥作用。Ontramab 150毫克注射液适用于经诊断患有特定形式癌症的患者，且该靶向治疗方法已显示出疗效。务必在合格医疗专业人员的指导下严格使用本药物。患者在开始治疗前应告知医生任何既往病史和正在服用的药物。常见的副作用可能包括疲劳、恶心和注射部位反应。请按照制造商的说明储存Ontramab 150毫克注射液，通常需要冷藏并避光保存。如果包装损坏或溶液出现变色，请勿使用。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Trastuzumab 150 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
